Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Umbelliferone β-D-galactopyranoside exerts an anti-inflammatory effect by attenuating COX-1 and COX-2
Vikas
Kumar
*a,
F. A.
Al-Abbasi
b,
Amita
Verma
a,
Mohd.
Mujeeb
c and
Firoz
Anwar
*bd
aDepartment of Pharmaceutical Sciences, Faculty of Health Sciences, Sam Higginbottom Institute of Agriculture, Technology & Sciences, Allahabad, India. E-mail: phvikas@gmail.com
bDepartment of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia. E-mail: firoz_anwar2000@yahoo.com
cDepartment of Pharmacognosy & Phytochemistry, Faculty of Pharmacy, Jamia Hamdard, New Delhi, India
dSiddhartha Institute of Pharmacy (SIP), Dehradun, India
First published on 5th August 2015
Abstract
Correction for ‘Umbelliferone β-D-galactopyranoside exerts an anti-inflammatory effect by attenuating COX-1 and COX-2’ by Vikas Kumar et al., Toxicol. Res., 2015, 4, 1072–1084.
The authors regret that on page 1074, the inflammatory mediators information is incorrect:
’Cytokine inflammatory mediators, like tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), interleukin-2 (IL-2), interleukin-1β (IL-1β) and interleukin-1α (IL-1α) were measured using ELISA kits (Biosource Int., Camarillo, CA, USA) according to the instructions provided by the manufacturer.23’
Should read:
‘Cytokine inflammatory mediators, like tumor necrosis factor-α (TNF-α) and interleukin-1 (IL-1) were measured using ELISA kits (Biosource Int., Camarillo, CA, USA) according to the instructions provided by the manufacturer.23’
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2015 |